automated patch clamp platforms (Chantest Inc)
Structured Review
Automated Patch Clamp Platforms, supplied by Chantest Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+patch+clamp+system+qpatch/automated+patch+clamp+system+qpatch/pm20095096-40-2-7
Average 90 stars, based on 1 article reviews
Images
Related Articles
Patch Clamp:Article Title: Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain Article Snippet: .. This broad selectivity screen was performed on an automated Article Title: Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain Article Snippet: .. This broad selectivity screen was performed on an automated Article Title: Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling. Article Snippet: TRPA1 is a non-selective cation channel expressed in sensory neurons where it functions as an irritant sensor for a plethora of electrophilic compounds and is implicated in pain, itch, and respiratory disease.. To study its function in various disease contexts, we sought to identify novel, potent and selective small molecule TRPA1 antagonists.. Herein we describe the evolution of an N-isopropyl glycine sulfonamide lead (1) to a novel and potent (4R,5S)-4-fluoro-5-methylproline sulfonamide series of inhibitors. Article Title: Identification and Characterization of GAL-021 as a Novel Breathing Control Modulator Article Snippet: Anesthesiology, V 123 • No 5 1093 November 2015 P ERIOPERATIVE sleep apnea is an epidemic,1 and a critical medical need exists for novel therapeutics to support breathing, maintain pain control, and lower hospital costs for surgical patients with sleep-disordered breathing.. GAL-021 is being developed as a novel breathing control modulator to preserve respiratory drive and protect patients from respiratory impairment due to opioids and other modalities.. Only caffeine, doxapram, and almitrine are currently used clinically as breathing control modulators and, in particular, as respiratory stimulants. Article Title: Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain Article Snippet: .. This broad selectivity screen was performed on an automated other:Article Title: Compositions and methods to modulate chloride ion channel activity Article Snippet: To identify a lead compound against CLC-2, we have worked with Article Title: Automated Electrophysiology Makes the Pace for Cardiac Ion Channel Safety Screening Article Snippet: In addition, a number of Article Title: Evaluation of a 125I-labelled benzazepinone derived voltage-gated sodium channel blocker for imaging with SPECT. Article Snippet: Voltage-gated sodium channels (VGSCs) are a family of transmembrane proteins that mediate fast neurotransmission, and are integral to sustain physiological conditions and higher cognitive functions.. Imaging of VGSCs in vivo holds promise as a tool to elucidate operational functions in the brain and to aid the treatment of a wide range of neurological diseases.. To assess the suitability of 1-benzazepin-2-one derived VGSC blockers for imaging, we have prepared a I-labelled analogue of BNZA and evaluated the tracer in vivo. Activity Assay:Article Title: Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling. Article Snippet: TRPA1 is a non-selective cation channel expressed in sensory neurons where it functions as an irritant sensor for a plethora of electrophilic compounds and is implicated in pain, itch, and respiratory disease.. To study its function in various disease contexts, we sought to identify novel, potent and selective small molecule TRPA1 antagonists.. Herein we describe the evolution of an N-isopropyl glycine sulfonamide lead (1) to a novel and potent (4R,5S)-4-fluoro-5-methylproline sulfonamide series of inhibitors. Inhibition:Article Title: Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling. Article Snippet: TRPA1 is a non-selective cation channel expressed in sensory neurons where it functions as an irritant sensor for a plethora of electrophilic compounds and is implicated in pain, itch, and respiratory disease.. To study its function in various disease contexts, we sought to identify novel, potent and selective small molecule TRPA1 antagonists.. Herein we describe the evolution of an N-isopropyl glycine sulfonamide lead (1) to a novel and potent (4R,5S)-4-fluoro-5-methylproline sulfonamide series of inhibitors. |
